Resources

Development of Small Molecule Enhancers for Improved Lentiviral-Based Cell Therapy Manufacturing: A NIIMBL Funded Project
May 19th, 2026PosterCell & Gene Therapies
Development of Small Molecule Enhancer Formulations for Optimized AAV Production in the ELEVECTA™ Transient Cell Line
May 19th, 2026PosterCell & Gene Therapies
Optimizing AAV Production Efficiency with CellVantage™ AAV: A Simple, Scalable Approach for Enhanced Upstream Yield
December 1st, 2025PosterCell & Gene Therapies
Enhancing Lentiviral Transduction Efficiency and Reducing MOI in Therapeutically Relevant Cell Types Using Small Molecule Viral Sensitizers
October 2nd, 2025PosterCell & Gene Therapies
Optimizing AAV Production Efficiency: A Scalable Approach Using Small Molecule Viral Sensitizers
October 2nd, 2025PosterCell & Gene Therapies
Small Molecule Antagonists of Cellular Innate Immunity for Enhanced Cell and Gene Therapy Manufacturing
June 14th, 2025PosterCell & Gene Therapies
Optimizing AAV Production: Accelerating Discovery of Small Molecule Enhancers using High Throughput Virology and Design of Experiments
May 10th, 2025PosterCell & Gene Therapies
End-to-End Optimization of CAR-T Manufacturing: Boosting Lentiviral Production and T-Cell Transduction with Viral Sensitizer Technology
May 10th, 2025PosterCell & Gene Therapies
High-Throughput Screening of Next Generation Small Molecule Enhancers and Process Automation in Cloud-Connected Bioreactors
April 20th, 2025PosterCell & Gene Therapies
Increased AAV Yield: From Screen to Scale Up to Cost Savings Using Viral Sensitizers (VSE™) Technology
April 20th, 2025PosterCell & Gene Therapies